José Pontes Junior

José Pontes Junior

Auto-generated profile, based on publicly available information

José Pontes Junior

Urology Department, LIM/55 ‐ Laboratory of urology Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo São Paulo SP Brazil

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2012 in BMC Urology
Verified
Journal Article
Open access
PDF file
SRSabrina Thalita Reis
Sabrina Thalita Reis
KLKatia Ramos Moreira Leite
Katia Ramos Moreira Leite
LPLuís Felipe Piovesan
Luís Felipe Piovesan
JPJosé Pontes-Junior
José Pontes-Junior
NVNayara Viana
Nayara Viana
MDMarcos Francisco Dall’oGlio
Marcos Francisco Dall’oGlio
Background: Extracellular matrix homeostasis is strictly maintained by a coordinated balance between the expression of metalloproteinases (MMPs) and their inhibitors. The purpose of this study was to investigate whether the expression of MMP-9, MMP-2 and its specific inhibitors, are expressed in a reproducible, specific pattern and if the profiles are related to prognosis in Bladder Cancer (BC). Methods: MMP-9, MMP-2 and its specific inhibitors expression levels were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) in fresh-frozen malignant tissue collected from 40 patients with BC submitted to transurethral resection of bladder. The control group consisted of normal bladder tissue from five patients who had undergone retropubic prostatectomy to treat benign prostatic hyperplasia. Results: MMP-9 was overexpressed in 59.0 % of patients, and MMP-2, TIMP-1, TIMP-2, MMP-14, RECK and IL-8 was underexpressed in most of the patients. Regarding prognostic parameters we observed that high-grade tumors exhibited significantly higher levels of MMP-9 and IL-8 (p = 0.012, p = 0.003). Invasive tumors (pT1-pT2) had higher expression levels of MMP-9 than superficial tumors (pTa) (p = 0.026). The same was noted for IL-8 that was more expressed by invasive tumors (p = 0.015, p = 0.048). Most importantly tumor recurrence was related with higher levels of both MMP-9 (p = 0.003) and IL-8 (p = 0.005). Conclusion: We have demonstrated that the overexpression of MMP-9 and higher expression of IL-8 are related to unfavorable prognostic factors of urothelial bladder cancer and tumor recurrence and may be useful in the follow up of the patients.

29 May 2012 in BMC Urology
Verified
Journal Article
Open access
PDF file
SRSabrina Thalita Reis
Sabrina Thalita Reis
JPJosé Pontes-Junior
José Pontes-Junior
AAAlberto Azoubel Antunes
Alberto Azoubel Antunes
MDMarcos Francisco Dall’oGlio
Marcos Francisco Dall’oGlio
NDNelson Dip
Nelson Dip
KLKatia Ramos Moreira Leite
Katia Ramos Moreira Leite
Prognosis of prostate cancer (PCa) is based mainly in histological aspects together with PSA serum levels that not always reflect the real aggressive potential of the neoplasia. The micro RNA (miRNA) mir-21 has been shown to regulate invasiveness in cancer through translational repression of the Metaloproteinase (MMP) inhibitor RECK. Our aim is to investigate the levels of expression of RECK and miR-21 in PCa comparing with classical prognostic factors and disease outcome and also test if RECK is a target of miR-21 in in vitro study using PCa cell line.

15 October 2015 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
KLKatia Ramos Moreira Leite
Katia Ramos Moreira Leite
SRSabrina T. Reis
Sabrina T. Reis
JJJosé Pontes Junior
José Pontes Junior
MZMarcelo Zerati
Marcelo Zerati
DGDaniel de Oliveira Gomes
Daniel de Oliveira Gomes
MSMiguel Srougi
Miguel Srougi
PD-L1 is a glycoprotein from the family of T-cell co-stimulatory molecules that are constitutively expressed by macrophages. Aberrant expression of PD-L1 is observed in human cancers associated with inhibition of the tumor-directed T-cell immune response. There are few reports in the literature evaluating PD-L1 expression in association to prognosis specifically in renal cell cancer clear cell type (RCC-CC). Immunohistochemistry using a PD-L1 polyclonal antibody was performed on a tissue microarray (TMA) that contained 115 surgical specimens of RCC-CC. Cases were classified based on the absence or presence of staining intensity in the cytoplasm and membranes of the tumor cells. Statistical analysis was used to determine the association of PD-L1 expression with classic prognostic factors and tumor recurrence. PD-L1 expression was positive in 56.5 % of tumors. The univariate analysis showed a correlation between PD-L1 expression and nuclear Fuhrman grade (p = 0.021) and microvascular tumor embolization (p = 0.039). One hundred and four patients were monitored for a mean time of 115.7 months. Seventeen patients (16.3 %) suffered tumor recurrence. Negative outcomes were associated with higher nuclear grade tumors, PD-L1 expression, and the presence of microvascular invasion. Our findings confirm that PD-L1 expression is an important prognostic factor in RCC-CC.

1 January 2009 in Journal of Carcinogenesis
Verified
Journal Article
Open access
PDF file
JPJosé Pontes-Júnior
José Pontes-Júnior
SRSabrina Thalita Reis
Sabrina Thalita Reis
MDMarcos Dall'Oglio
Marcos Dall'Oglio
LOLuis Carlos Neves De Oliveira
Luis Carlos Neves De Oliveira
JCJose Cury
Jose Cury
MSMiguel Srougi
Miguel Srougi
Background: Integrins and adhesion molecules are responsible for the maintenance of the epithelial phenotype. Cell culture studies have reported the correlation between adhesion molecule expression and prostate carcinoma, but their role in the metastatic process is not yet known. Our aim is to study the expression profiles of these molecules and evaluate their association with the metastatic behavior of prostate adenocarcinoma. Materials and Methods: A Tissue Microarray containing two samples from 19 primary tumors and one from their corresponding lymph node metastases was constructed and subjected to immunohistochemical analysis of the expression of integrins, E-cadherin and β and γ-catenins. Within each case, paired analyses were also performed to evaluate gains or losses in metastasis compared to its primary tumor. Results: The expression of av, αvβ 3, α2β 1 and γ-catenin were abnormal in almost every case. Marked loss of E-cadherin and β 4 integrin was found in primary and metastatic lesions. β -catenin was normal in all primary cases and in 94% of metastases. a6 was normal in all primary tumors and metastases. α3 and α3β 1 were normal in 32% of primary cases and in 53% and 6% of metastases, respectively. In paired analyses, loss of E-cadherin, β 4, αv, α3β 1 and αvβ 3 was found in 65%, 71%, 59%, 53% and 47% of patients, respectively. Catenins and α2β 1 showed maintenance of expression in most of the cases. Conclusions: In this preliminary study we have shown that the loss of cell adhesion molecules can be considered a characteristic of the metastatic phenotype in prostate cancer. Larger series should be evaluated in order to confirm our findings.

17 June 2010 in The Prostate
Verified
Journal Article
Closed access
PDF file
JPJosé Pontes‐Júnior
José Pontes‐Júnior
SRSabrina Thalita Reis
Sabrina Thalita Reis
LOLuis Carlos Neves de Oliveira
Luis Carlos Neves de Oliveira
ASAlexandre C. Sant'ANna
Alexandre C. Sant'ANna
MDMarcos Francisco Dall'OGlio
Marcos Francisco Dall'OGlio
KLKatia Ramos Moreira Leite
Katia Ramos Moreira Leite

1 March 2010 in Applied Immunohistochemistry & Molecular Morphology
Verified
Journal Article
Closed access
JJJose Pontes Junior
Jose Pontes Junior
MSMiguel Srougi
Miguel Srougi
PBPriscila M. A. Borra
Priscila M. A. Borra
MOMarcos F. Dall' Oglio
Marcos F. Dall' Oglio
LRLeopoldo A. Ribeiro-Filho
Leopoldo A. Ribeiro-Filho
KLKatia Ramos Moreira Leite
Katia Ramos Moreira Leite
Objectives E-cadherin and β-catenin are adhesion molecules responsible for the maintenance of normal epithelial cell phenotype. A disturbance in epithelial cell adhesion, which leads to a more invasive and metastatic phenotype, is a hallmark of tumor progression. Several immunohistochemical studies have reported a strong correlation between loss of their expression to higher stage and grade in prostate carcinoma, but their influence in metastatic process is not yet known. The aim of this study is to verify the role of adhesion molecules in the progression of prostate cancer (PC), assessing the expression of E-cadherin and β-catenin in bone metastasis. Materials and Methods Twenty-eight bone metastases of prostate carcinoma were submitted to immunohistochemistry analysis for E-cadherin and β-catenin expression. In 6 patients, we were able to assess the expression of the adhesion molecules in the primary tumors and their respective metastases. The definition of normal expression for both antibodies was strong and diffuse expression in more than 70% of tumor cells. Results In bone metastases, there was loss of expression of E-cadherin and β-catenin in 86% and 82%, respectively. Among the primary tumors, E-cadherin and β-catenin expression was normal in 83% and 50% cases, respectively. Considering the 6 patients with paired primary and bone metastasis, we found loss of expression for both E-cadherin and β-catenin in most of the cases. Conclusions Comparing primary PC and its metastasis, we showed persistent loss of E-cadherin and β-catenin expression. This phenomenon may be related to metastatic potential in PC, because we have shown underexpression for E-cadherin and β-catenin in 86% and 82% of bone metastases.